NIH-funded research R01 grant

Gut microbiome and heart disease risk in Asian American and Pacific Islander adults

Official title: Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome

Funded at New York University School of Medicine · NIH-11418013 · Data updated 2026-11-12

A Johns Hopkins-style patient-friendly summary: this study will look at how the gut microbiome relates to early heart artery changes in AsA-NHPI adults to help prevent heart disease.

More Gut Microbiome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 12, 2025
Project endJune 30, 2029
Funding year2026
Award (this year)$2,202,194
NIH project number5R01HL178710-02
Project IDNIH-11418013 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years or older who identify as Asian American, Native Hawaiian, or Pacific Islander and have or are at risk for ASCVD.

Less likely to help

People outside the AsA-NHPI groups or those without interest in microbiome-based prevention may not benefit.

What this research studies

This project will recruit AsA-NHPI adults and collect gut microbiome samples, CAC imaging, and clinical data to explore links between gut bacteria, fungi, and viruses with early coronary artery calcification. Researchers will compare microbiome profiles across subgroups and examine how these profiles relate to traditional risk factors and CAC scores. By integrating microbial data with heart-artery imaging, the study aims to identify microbiome patterns that could inform personalized prevention strategies. The work builds on preliminary findings showing distinct microbiomes in AsA-NHPI populations and potential associations with early atherosclerosis. Ultimately, results could guide new, microbiome-informed approaches to reducing cardiovascular risk in these communities.

Why it matters

Potential benefit: If successful, the study could lead to personalized prevention strategies for heart disease based on an individual's gut microbiome.

How similar studies have gone: Preliminary data suggest distinct microbiome profiles in AsA-NHPI individuals and links to early atherosclerosis, but human data in these populations are limited.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Ahn, Jiyoung — New York University School of Medicine
  • Study coordinator: Ahn, Jiyoung

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.